Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant in Smoking Cessation (STRATUS US)
NCT00358228Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2002
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rimonabant in Tobacco Use Disorder (TUD), sponsored by Sanofi. Started Sep 2002; status: completed.
02
Drugs
rimonabant
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00358228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358228.